#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4252210	Functional	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
2.	ALA4252211	Functional	Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 48 hrs by MTT assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
3.	ALA4252212	Functional	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
4.	ALA4252213	Functional	Cytotoxicity against human A549 cells assessed as reduction in cell viability after 48 hrs by MTT assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
5.	ALA4252214	Functional	Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay	Mus musculus	29	ALA4251560	cell-based format	Scientific Literature
6.	ALA4252215	Functional	Cytotoxicity against mouse EAC cells assessed as reduction in cell viability after 48 hrs by MTT assay	Mus musculus	29	ALA4251560	cell-based format	Scientific Literature
7.	ALA4252216	Functional	Cytotoxicity against mouse DLA cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay	Mus musculus	29	ALA4251560	cell-based format	Scientific Literature
8.	ALA4252217	Functional	Cytotoxicity against mouse DLA cells assessed as reduction in cell viability after 48 hrs by MTT assay	Mus musculus	29	ALA4251560	cell-based format	Scientific Literature
9.	ALA4252218	Functional	Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by trypan blue exclusion assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
10.	ALA4252219	Functional	Cytotoxicity against human MDA-MB-468 cells assessed as reduction in cell viability after 48 hrs by MTT assay	Homo sapiens	29	ALA4251560	cell-based format	Scientific Literature
11.	ALA4252220	Functional	Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as decrease in tumor volume at 25 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
12.	ALA4252221	Functional	Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as decrease in tumor volume at 50 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
13.	ALA4252222	Functional	Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as decrease in tumor volume administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
14.	ALA4252223	Functional	Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as reduction in cell density administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
15.	ALA4252224	Functional	Antitumor activity against mouse EAC cells implanted in ip dosed Swiss albino mouse assessed as reduction in ascite volume administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
16.	ALA4252225	Functional	Antitumor activity against mouse EAC cells implanted in Swiss albino mouse assessed as mouse survival at 25 to 50 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
17.	ALA4252226	Toxicity	Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as induction of adverse effect on liver at 25 to 50 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
18.	ALA4252227	Toxicity	Toxicity in Swiss albino mouse implanted with mouse EAC cells assessed as induction of adverse effect on spleen at 25 to 50 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
19.	ALA4252228	Functional	Antitumor activity against mouse EAC solid tumor implanted in Swiss albino mouse assessed as reduction in tumor mass at 25 mg/kg, ip administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature
20.	ALA4252229	Functional	Antitumor activity against mouse EAC solid tumor implanted in ip dosed Swiss albino mouse assessed as reduction in tumor volume administered every alternate day for 3 days	Mus musculus	1	ALA4251560	organism-based format	Scientific Literature